Perfectha Filler: Versions, Evidence and Recovery

Someone suggested Perfectha for your lips, folds or lost cheek volume. Is it one filler or several, how does it differ from familiar names, and will you still look like yourself? Perfectha is a range of absorbable hyaluronic-acid fillers, not one universal injection. Its gels have different structures and intended placement depths. Matching the exact version to the goal and a safe anatomical plane matters more than the brand name or a promise of lasting results.

What is Perfectha, and who determines how it may be used?

Perfectha is associated with Sinclair; its official website describes manufacture of hyaluronic-acid gels in Lyon, France. Hyaluronic acid retains water and provides tissue volume. In a filler it is stabilised so that the injected gel does not disappear immediately. The manufacturer describes its E-BRID technology and 20 mg/mL hyaluronic-acid concentration across the listed versions, with different particle sizes and mechanical behaviour. Equal concentration does not imply identical firmness, indications or results.

The manufacturer lists FINELINES, DERM, DEEP and SUBSKIN, including some lidocaine-containing variants; lidocaine is a local anaesthetic. Packaging, registration and instructions may differ by country and product generation. The availability of one version never proves the entire range is available, and indications for DEEP cannot simply be transferred to FINELINES. Lawful registration and actual supply of each variant in Armenia must be checked separately: an international webpage is not proof.

The CE marking mentioned in the brand history relates to its applicable European regulatory context. It does not in itself establish registration in Armenia, US FDA approval or permission for every facial area. Check the current instructions for use (IFU), labelling, expiry date, batch number and regulatory status in the country where the injection will actually take place. If a practitioner cannot identify the precise version or show appropriate documents, it is reasonable to postpone consent.

How do the different Perfectha versions compare?

The manufacturer's descriptions range from fine surface lines to more substantial volume loss. This table explains the manufacturer's product logic; it is neither a self-selection guide nor permission to inject a listed area. The current locally applicable IFU sets the authorised indications, prohibited sites and placement planes. A suitably qualified clinician must decide on treatment after examining you.

One critical detail is easily missed in advertising: the official site expressly warns against injecting DERM, DEEP and SUBSKIN into the periorbital region or between the eyebrows because vascular complications may lead to vision loss. For lidocaine-containing FINELINES near the eyes, the manufacturer also urges particular caution and warns of ocular ischaemia. Even when another brand page names the under-eye region as a possible site, that does not make it a routine, risk-free procedure. The locally valid IFU takes priority.

DEEP does not mean “longest lasting, therefore best.” The gel's intended depth, capacity to hold its shape, needed amount and anatomical goal must agree. Placing a firmer gel too superficially may cause visible outlines or lumps; too much gel in any plane can alter proportions in unexpected ways. Discuss both the static appearance and the way your face will look when smiling.

The range page also mentions SOOF—the fat compartment beneath the orbicularis oculi muscle near the lower eyelid—for DEEP. Yet the manufacturer’s general warning prohibits injecting DEEP into the periorbital region. A promotional list cannot establish where permitted use begins or ends: the current local instructions and the treating physician must clarify that boundary before any injection near the eye.

How can you identify the change you actually want?

For lips, the aim might be a clearer edge, a small asymmetry correction or more volume; these are three different goals. Softening lines near the mouth differs from building cheek projection: tissue behaviour during movement is essential in the former, light and shadow balance in the latter. When sagging is the main issue, adding gel will not always provide a lift and may make the lower face heavier. A volumising filler does not treat rosacea, pigmentation or wrinkles predominantly caused by muscle movement.

A natural result does not have to mean no visible change. It means proportions and expressions still fit your anatomy and wishes. Sometimes a smaller quantity followed by reassessment is safer and more convincing than treating everything in one visit. An “ideal dose” cannot responsibly be fixed without an examination. You could say: “I want my face to feel familiar when it moves; what can realistically change, and what cannot?”

What does the evidence show — and not show?

Perfectha's manufacturer reports its own clinical experience and satisfaction data. Findings from particular studies or post-market observations are not proof that the entire range outperforms all other hyaluronic-acid fillers. Testing one formula in nasolabial folds neither authorises another one near the eyes nor establishes how long a lip result will last. Studies of hyaluronic-acid fillers as a class support correction of volume and selected wrinkles when used appropriately, but do not identify one winner for everybody.

A random review after an injection is especially weak evidence about the product. Visible results depend on starting proportions, technique, amount of gel, time elapsed and photography. Swelling and fluid can make lips look fuller an hour afterwards than after recovery. Images with different camera angles or lighting cannot fairly compare brands. Reviews of Perfectha Deep address a different question: the range should be selected first by the IFU, safety and personal anatomy. Reviews of Perfectha Deep

When comparing names such as Revolax and MaiLi, compare exact formulations and treatment areas, not words such as “soft,” “flexible” or “premium.” Sharing hyaluronic acid places products in the same broad category, but their physical behaviour and regulatory files differ. Among publications reviewed through October 2026, high-quality direct comparisons of all formulations for each area are insufficient to create a defensible overall ranking. Revolax fillers MaiLi fillers

The first visible change and the duration of a result are different questions. The manufacturer describes effects lasting “up to 18 months” in certain areas and shorter indicative periods in mobile areas such as the lips. These are manufacturer-published estimates for particular formulations and sites, not promises for every Perfectha variant or for your anatomy. At follow-up, the remaining volume, symmetry and your preferences should be assessed; another injection is not automatically necessary simply because an advertised interval has passed.

What will happen at the appointment, and what will it feel like?

First the clinician asks about your health: allergies, particularly to ingredients and anaesthetics; previous fillers; skin infection; medicines affecting bleeding; operations; and current symptoms. Next comes an assessment at rest and while moving, agreed photographs, the treatment plan, approximate volume and order of areas. Before treatment, sterile packaging integrity, product identity and expiry date should be checked. You may ask to see these details.

Skin is cleaned, then the gel is introduced using a needle or cannula according to the product, area and clinical plan. You may feel pricks, pressure or fullness; lidocaine may lessen discomfort without guaranteeing a pain-free experience. Report severe sudden pain or skin colour changes immediately. The clinician should explain in advance how vascular compromise is recognised and what emergency actions can be taken in the clinic.

Hyaluronic-acid gel can sometimes be broken down with the enzyme hyaluronidase, but this is not an instant, risk-free “undo” for every problem. More than one treatment may be needed, tissue injury can remain, and vascular emergencies may be time-critical within minutes. In high-risk areas, “we can always dissolve it later” is not an adequate safety explanation.

Recovery: what is expected, and what is not?

Mild swelling, tenderness, redness and bruising are common after injections. They may show for days and sometimes longer. The final contour is not immediately clear: swelling can be uneven, and near sensitive sites it can notably change appearance. Before a wedding, public event or on-camera work, do not assume next-day invisibility. Agree on a personal buffer rather than trusting one universal recovery promise.

The manufacturer's global website advises no makeup for 24 hours and avoiding prolonged ultraviolet exposure and extreme heat or cold, including saunas, for roughly 2–3 weeks. Check whether this advice applies to your formulation against local IFU and clinician instructions. Do not press or massage the treated area without instruction. Never stop prescribed anticoagulants, aspirin or other medicines on your own to accommodate a cosmetic appointment: the treating doctor must weigh clotting and bleeding risks.

Seek immediate medical assessment for unusual severe pain, sudden blanching or mottled darkening of skin, rapidly worsening discolouration, impaired vision, double vision, severe headache or neurological symptoms following injection. These may signal compromised blood flow; do not wait for a supposed bruise to fade. Persistent spreading redness, heat, painful lumps, fever or discharge call for prompt clinician contact to rule out infection or other complications. Late nodules and inflammatory reactions can also occur months later.

Who should postpone or avoid injections?

Sinclair's global information lists restrictions including sensitivity to hyaluronic acid, lidocaine or amide-type anaesthetics, inflammation or infection at the injection site, pregnancy, breastfeeding, childhood, and certain diseases and ongoing therapies. Its more extensive list includes autoimmune disease, uncontrolled epilepsy, a tendency toward prominent scarring and other conditions. Do not diagnose your own exclusion from one label: the clinician must consult the precise local IFU, assess its relevance to you and, when needed, coordinate with your other doctors.

Permanent implants, unknown past injected materials and complications after previous fillers deserve special attention. The manufacturer restricts mixing and injections into areas containing certain pre-existing materials. If you cannot identify an injection received years ago, try to recover the record and seek assessment or imaging when appropriate. And if your only motivation is that “everyone gets their lips done,” declining requires no medical justification.

How to decide without pressure

Ask for the written name and formulation of Perfectha, instructions valid where you will be treated, batch number and intended anatomical site. Ask why it is preferable to a smaller amount of another suitable product or to no filler; what remains unpredictable; what costs beyond the injection itself; whether follow-up is included; and who is available during evenings or weekends. Price depends on more than syringe volume: assessment, anatomical complexity, technique and aftercare matter. A universal price would be misleading.

If several areas are proposed, ask which steps are necessary and which optional. If the explanation rests on claims like “newest,” “absolutely safe” or “approved everywhere,” request the supporting documentation and studies. You need not decide on consultation day. A worthwhile outcome is knowing your goal, the limits, exact version and support plan — even if you decide on no intervention for now.